MediciNova
Develops in-licensed small molecules across neurodegenerative, metabolic, and fibrotic diseases.
$1.44
After-hours close0.00 (0.00%)
At close$1.44(+1.06%)
Something off on this page? Send us feedback.
Breakdown13F · Form 4
Institutions 10.98%Insiders —
Shares outstanding 49.22M · Float 42.26M · 85.9% free float
Insiders — no current Form 4 position.
Institutions13F, as of Mar 31, 2026
30 holders · 5.40M shares · 5 new positions · 13 increased · 9 reduced · 8 closed
| Holder | Shares | % outstanding | Chg q/q | Filed |
|---|---|---|---|---|
| Essex Woodlands Management, Inc. | 1.11M | 2.25% | 0 | May 4, 2026 |
| BlackRock, Inc. | 706.0K | 1.43% | +984 | May 13, 2026 |
| Citigroup Inc | 635.7K | 1.29% | 0 | May 11, 2026 |
| Vanguard Capital Management LLC | 611.0K | 1.24% | +611.0Knew | May 15, 2026 |
| Geode Capital Management, LLC | 543.8K | 1.10% | +14.3K | May 15, 2026 |
| Vanguard Fiduciary Trust Co | 280.6K | 0.57% | +280.6Knew | May 8, 2026 |
| UBS Group AG | 222.2K | 0.45% | −3.5K | May 5, 2026 |
| State Street Corp | 193.7K | 0.39% | 0 | May 15, 2026 |
Beneficial owners13D/G · 5% or more, as filed
No 13D/G filer at 5% or more on record.
InsidersForm 4
No current Form 4 position on record.
5 ten-percent owners hold 23.47M shares by Form 4, outside the officers-and-directors figure above · 15 people have not refiled in the last 18 months (14.93M shares), so they are not in the figure above
Latest trades
No open-market trades in the last 12 months.
CongressHouse and Senate disclosures
Not reported.